MOSCOW, RUSSIA — AUGUST 12, 2020: Ampoules with a COVID-19 vaccine developed by the Gamalei Scientific Research Institute of Epidemiology and Microbiology of the Russian Healthcare Ministry. Gam-COVID-Vac is a vector two-component adenovirus based vaccine. The vaccine will be available to general public on January 1, 2021. Mikhail Japaridze/TASS

îññèß. Œîñêâà. ‚àêöèíà äëß ïðîôèëàêòèêè íîâîé êîðîíàâèðóñíîé èíôåêöèè COVID-19, ðàçðàáîòàííàß àöèîíàëüíûì èññëåäîâàòåëüñêèì öåíòðîì ýïèäåìèîëîãèè è ìèêðîáèîëîãèè èìåíè àêàäåìèêà .”. ƒàìàëåè Œèíçäðàâà îññèè. ƒàì-ŠŽ‚ˆ„-‚àê — âåêòîðíàß äâóõêîìïîíåíòíàß âàêöèíà íà îñíîâå àäåíîâèðóñà ÷åëîâåêà. ‚ ãðàæäàíñêèé îáîðîò ïðåïàðàò ïîñòóïèò 1 ßíâàðß 2021 ãîäà. Œèõàèë „æàïàðèäçå/’€‘‘